CardioVascular Services & Nuclear Medicine Manager, CHI Saint Joseph Berea Heart & Vascular Care 2020 CHI Saint Joseph Health Berea Leader of the Year
Thankful to be a contributing part of the Nuclear Medicine community to aid in the detection, diagnosis, and treatment for Cardiac Amyloidosis. The Tc99m-PYP scan is a non-invasive study with both high sensitivity and specificity in detecting the disease. Once these patients are diagnosed, new treatments aid in halting the disease progression, allowing for an increased quality of life as well as extending their life. Great article from SNMMI: https://lnkd.in/eGbiamFk #nuclearmedicine #snmmi #asnc
Renaissance: a revival of or renewed interest in something. This month's Uptake explores the rising interest in diagnosing cardiac amyloidosis. Once thought to be rare, this cardiac condition is driving the demand for Tc-99m pyrophosphate (PYP) scans. With its increased sensitivity and specificity, this nuclear medicine scan can diagnose cardiac amyloidosis noninvasively and with less risk, and the rise in accurate diagnosis has also spurred treatment innovations. Will these scans continue to be in demand? Find out in this month's Uptake! Thanks to this month's Uptake authors Jaime Warren, Ed.D, MBA, MHS, CNMT, FACC, and Mary Beth Farrell, Ed.D, CNMT, NCT, RT(N), FSNMMI-TS. Read the entire article here: https://lnkd.in/eGbiamFk #nuclearmedicine #nucmedtech #hearthealth